Bayesian Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Bayesian Capital Management’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,900	Closed	-$998K	–	1027
2019 Q4	$998K	Buy	+12,900	New	+$911K	0.17%	176
2018 Q1	–	Sell	-13,066	Closed	-$764K	–	872
2017 Q4	$764K	Buy	+13,066	New	+$741K	0.16%	223
2016 Q2	–	Sell	-8,300	Closed	-$404K	–	580
2016 Q1	$404K	Buy	+8,300	New	+$377K	0.38%	80

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Bayesian Capital Management's NUVA Position: Q1 2020 in Review

Bayesian Capital Management sold out of NuVasive, Inc. (NUVA) in Q1 2020, closing a stake of 12,900 shares — an estimated $998K sold.

Bayesian Capital Management first reported a position in NUVA in Q1 2016 and held it in 3 quarters. The position peaked at $998K in Q4 2019. 266 funds tracked by Wall St. Rank hold NUVA as of Q1 2020.

Bayesian Capital Management reported no remaining NuVasive, Inc. position as of Q1 2020 after selling out during the quarter.
Bayesian Capital Management sold 12,900 NuVasive, Inc. shares in Q1 2020, an estimated $998K.
Bayesian Capital Management first reported a position in NuVasive, Inc. in Q1 2016 and held it in 3 quarters.
Bayesian Capital Management's NuVasive, Inc. position peaked at $998K in Q4 2019.
266 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2020.

Based on Bayesian Capital Management's 13F filing for Q1 2020, filed 15 May 2020.